Evidence map›Paper›PMID 34954817›Full record

ArticleAnnals of neurology2022

Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes.

Michael Zech, Robert Kopajtich, Katja Steinbrücker, Céline Bris, Naig Gueguen, René G Feichtinger, Melanie T Achleitner, Neslihan Duzkale, Maximilien Périvier, Johannes Koch and 24 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Dystonia: Insights into Mechanisms and Novel Therapeutics.Current neurology and neuroscience reports · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Biallelic variants inmedRxiv : the preprint server for health sciences · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 16 institutions in 9 countries.

Michael Zech *Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.ORCID 0000-0001-8112-9153
Robert Kopajtich *Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.ORCID 0000-0002-9119-3455
Katja Steinbrücker *University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Céline BrisUnité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Université d'Angers, Angers, France.
Naig GueguenUnité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Université d'Angers, Angers, France.
René G FeichtingerUniversity Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.ORCID 0000-0002-4215-8258
Melanie T AchleitnerUniversity Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Neslihan DuzkaleDepartment of Medical Genetic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
Maximilien PérivierPediatric Neurology Department, CHU Clocheville, Tours, France.
Johannes KochUniversity Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Harald EngelhardtKinderkrankenhaus St. Marien gGmbH, Zentrum für Kinder- und Jugendmedizin, Landshut, Germany.
Peter FreisingerChildren's Hospital Kreiskliniken, Reutlingen, Germany.
Matias WagnerTechnical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.ORCID 0000-0002-4454-8823
Theresa BrunetTechnical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.ORCID 0000-0002-5183-780X
Riccardo BeruttiTechnical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Dmitrii SmirnovTechnical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.ORCID 0000-0002-5802-844X
Tharsini NavaratnarajahDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Richard J T RodenburgRadboud Centre for Mitochondrial Medicine, Department of Paediatrics Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen Medical Centre Nijmegen, Nijmegen, The Netherlands.
Lynn S PaisProgram in Medical and Population Genetics, Broad Institute, Cambridge, MA.
Christina Austin-TseHarvard Medical School & Center for Genomic Medicine, Massachusetts General Hospital, Boston & Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, MA.
Melanie O'LearyBroad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA.
Sylvia BoeschDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Robert JechDepartment of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Somayeh BakhtiariPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ.
Sheng Chih JinDepartment of Genetics, Washington University School of Medicine, St. Louis, MO.
Friederike WilbertDepartment of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Michael C KruerPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ.
Saskia B WortmannUniversity Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Matthias EckenweilerDepartment of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Johannes A MayrUniversity Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Felix DistelmaierDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Robert SteinfeldDepartment of Pediatric Neurology, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
Juliane Winkelmann *Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Holger Prokisch *Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.ORCID 0000-0003-2379-6286
Helmholtz Zentrum München · DEParacelsus Medical University · ATBarrow Neurological Institute · USBroad Institute · USCentre National de la Recherche Scientifique · FRDüsseldorf University Hospital · DERadboud University Nijmegen · NLUniversity of Freiburg · DECentre Hospitalier Universitaire de Tours · FRCharles University · CZDışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi · TRHarvard University · USInnsbruck Medical University · ATKreiskliniken Reutlingen · DEUniversity of Zurich · CHWashington University in St. Louis · US

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Broad Institute Mendelian Genomic Research CenterU01HG011755 · NHGRI · BROAD INSTITUTE, INC. · PI Anne O'Donnell-Luria, MICHAEL E TALKOWSKI · 2021 to 2026
$14.6M
Genomic Insights into the Neurobiology of Cerebral PalsyR01NS106298 · NINDS · UNIVERSITY OF ARIZONA · PI KRUER, MICHAEL C · 2019 to 2023
$3.7M
A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
Integrative Genomic Analysis of Congenital Heart DiseaseR00HL143036 · NHLBI · WASHINGTON UNIVERSITY · PI JIN, SHENG CHIH · 2020 to 2022
$730k
Austrian Science Fund FWF I 4695Charles UniversityElse Kröner-Fresenius-StiftungFederal Ministry of Education and Research 01GM1906AFederal Ministry of Education and Research 01GM1920AFederal Ministry of Education and Research 01KU2016AFederal Ministry of Education and Research I4695-BFederal Ministry of Education and Research I4704-BHelmholtz Zentrum MünchenMedizinische Universität InnsbruckMinistry of Education NV19-04-00233NHGRI NIH HHS R01 HG009141NHGRI NIH HHS U01 HG011755NHGRI NIH HHS UM1 HG008900NHLBI NIH HHS R00 HL143036NINDS NIH HHS R01 NS106298Research FoundationTechnische Universität München
6 · The paper itself

Abstract

objectiveATP synthase (ATPase) is responsible for the majority of ATP production. Nevertheless, disease phenotypes associated with mutations in ATPase subunits are extremely rare. We aimed at expanding the spectrum of ATPase-related diseases.

methodsWhole-exome sequencing in cohorts with 2,962 patients diagnosed with mitochondrial disease and/or dystonia and international collaboration were used to identify deleterious variants in ATPase-encoding genes. Findings were complemented by transcriptional and proteomic profiling of patient fibroblasts. ATPase integrity and activity were assayed using cells and tissues from 5 patients.

resultsWe present 10 total individuals with biallelic or de novo monoallelic variants in nuclear ATPase subunit genes. Three unrelated patients showed the same homozygous missense ATP5F1E mutation (including one published case). An intronic splice-disrupting alteration in compound heterozygosity with a nonsense variant in ATP5PO was found in one patient. Three patients had de novo heterozygous missense variants in ATP5F1A, whereas another 3 were heterozygous for ATP5MC3 de novo missense changes. Bioinformatics methods and populational data supported the variants' pathogenicity. Immunohistochemistry, proteomics, and/or immunoblotting revealed significantly reduced ATPase amounts in association to ATP5F1E and ATP5PO mutations. Diminished activity and/or defective assembly of ATPase was demonstrated by enzymatic assays and/or immunoblotting in patient samples bearing ATP5F1A-p.Arg207His, ATP5MC3-p.Gly79Val, and ATP5MC3-p.Asn106Lys. The associated clinical profiles were heterogeneous, ranging from hypotonia with spontaneous resolution (1/10) to epilepsy with early death (1/10) or variable persistent abnormalities, including movement disorders, developmental delay, intellectual disability, hyperlactatemia, and other neurologic and systemic features. Although potentially reflecting an ascertainment bias, dystonia was common (7/10).

interpretationOur results establish evidence for a previously unrecognized role of ATPase nuclear-gene defects in phenotypes characterized by neurodevelopmental and neurodegenerative features. ANN NEUROL 2022;91:225-237.

Indexed as

DystoniaEpilepsyExome SequencingGenetic VariationHumansMitochondriaMitochondrial ADP, ATP TranslocasesMitochondrial DiseasesMitochondrial Proton-Translocating ATPasesModels, MolecularMutationMutation, MissenseNervous System DiseasesNeurodegenerative DiseasesNeurodevelopmental DisordersPedigreeATP5F1A protein, humanATP5PD protein, humanMitochondrial ADP, ATP TranslocasesMitochondrial Proton-Translocating ATPases

Identifiers

PMID34954817
PMCPMC9939050
OpenAlexW4200408469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.